Medicamen Biotech Ltd consolidated Q1FY24 PAT up at Rs. 4.17 crore

MEDICAMEN BIOTECH LTD. has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 42.3223 crores during the period ended June 30, 2023 as compared to Rs. 39.0119 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 4.1772 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 3.8897 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 3.12 for the period ended June 30, 2023 as compared to Rs. 3.03 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 42.3223 crs	₹39.0119 crs	8.49%
Net Profit	₹4.1772 crs	₹3.8897 crs	7.39%
EPS	₹3.12	₹3.03	2.97%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 42.3223 crores during the period ended June 30, 2023 as compared to Rs.34.0503 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.4.1772 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.3.5856 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.3.12 for the period ended June 30, 2023 as compared to Rs.2.94 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 42.3223 crs	₹34.0503 crs	24.29%
Net Profit	₹4.1772 crs	₹3.5856 crs	16.50%
EPS	₹3.12	₹2.94	6.12%

Shares of MEDICAMEN BIOTECH LTD. was last trading in BSE at Rs. 826.70 as compared to the previous close of Rs. 823.30. The total number of shares traded during the day was 4655 in over 493 trades.

The stock hit an intraday high of Rs. 843.00 and intraday low of 815.00. The net turnover during the day was Rs. 3873036.00.

Source : Equity Bulls

Keywords

MedicamenBiotech Q1FY24 ResultUpdate